Research AI

Scans

Tools

Watchlists

Home

Charts

Watchlist

Products

Astrazeneca Pharma India Ltd

ASTRAZEN

NSE

₹6,039.50+1.16%19 Oct 2026

Reports

Pharma MNC Bulk Drugs

Astrazeneca Pharma India Ltd

ASTRAZEN

NSE

₹6,039.50

+1.16%

19 Oct 2026

SOICxStockScans Reports

Ask AI

Pharma MNC Bulk Drugs

Indices

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Quick Ratios

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Peer Comparison

Price

Charts

Documents

Edit Ratios

Mkt Cap

Market Capitalization

₹15,185Cr

Close Price

₹6,074.00

Industry

Pharma MNC Bulk Drugs

Price To Earnings

89.52

Price To Sales

6.24

Revenue

₹2,432Cr

Rev Gr TTM

Revenue Growth TTM

31.10%

PAT Gr TTM

PAT Growth TTM

-7.49%

Standalone

Numbers

Percentage

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	311	306	383	388	408	440	480	526	559	612	579	683
Growth YoY Revenue Growth YoY%	31.7	22.4	34.6	31.1	31.2	44.0	25.4	35.8	37.0	38.9	20.4	29.7
Expenses ExpensesCr	258	291	334	349	355	363	394	445	484	567	518	634
Operating Profit Operating ProfitCr	53	15	49	38	53	77	86	81	75	45	61	49
OPM OPM%	17.0	4.9	12.9	9.8	12.9	17.5	18.0	15.4	13.4	7.3	10.5	7.2
Other Income Other IncomeCr	25	10	9	-49	8	-26	10	11	1	7	5	9
Interest Expense Interest ExpenseCr	1	1	0	0	0	0	1	1	1	1	2	2
Depreciation DepreciationCr	4	4	4	4	9	9	18	17	3	4	6	5
PBT PBTCr	73	20	54	-15	51	42	78	75	73	47	58	51
Tax TaxCr	21	5	15	-3	13	11	20	19	19	14	13	13
PAT PATCr	52	16	39	-12	38	31	58	56	54	33	45	38
Growth YoY PAT Growth YoY%	60.8	-46.1	128.6	-121.9	-26.6	95.3	47.5	573.5	41.1	5.6	-22.9	-32.1
NPM NPM%	16.8	5.2	10.3	-3.0	9.4	7.0	12.1	10.6	9.7	5.3	7.8	5.6
EPS EPS₹	20.9	6.3	15.8	-4.7	16.4	12.3	23.3	22.3	21.7	13.0	17.9	15.2

Quarter	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue RevenueCr	311	306	383	388	408	440	480	526	559	612	579	683
Growth YoY Revenue Growth YoY%	31.7	22.4	34.6	31.1	31.2	44.0	25.4	35.8	37.0	38.9	20.4	29.7
Expenses ExpensesCr	258	291	334	349	355	363	394	445	484	567	518	634
Operating Profit Operating ProfitCr	53	15	49	38	53	77	86	81	75	45	61	49
OPM OPM%	17.0	4.9	12.9	9.8	12.9	17.5	18.0	15.4	13.4	7.3	10.5	7.2
Other Income Other IncomeCr	25	10	9	-49	8	-26	10	11	1	7	5	9
Interest Expense Interest ExpenseCr	1	1	0	0	0	0	1	1	1	1	2	2
Depreciation DepreciationCr	4	4	4	4	9	9	18	17	3	4	6	5
PBT PBTCr	73	20	54	-15	51	42	78	75	73	47	58	51
Tax TaxCr	21	5	15	-3	13	11	20	19	19	14	13	13
PAT PATCr	52	16	39	-12	38	31	58	56	54	33	45	38
Growth YoY PAT Growth YoY%	60.8	-46.1	128.6	-121.9	-26.6	95.3	47.5	573.5	41.1	5.6	-22.9	-32.1
NPM NPM%	16.8	5.2	10.3	-3.0	9.4	7.0	12.1	10.6	9.7	5.3	7.8	5.6
EPS EPS₹	20.9	6.3	15.8	-4.7	16.4	12.3	23.3	22.3	21.7	13.0	17.9	15.2

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	564	544	571	728	832	814	806	1,003	1,296	1,716	2,276	2,432
Growth Revenue Growth%	9.0	-3.5	5.0	27.6	14.2	-2.2	-1.0	24.5	29.2	32.5	32.6	31.1
Expenses ExpensesCr	547	507	525	657	711	678	719	838	1,111	1,462	2,014	2,202
Operating Profit Operating ProfitCr	16	37	46	71	121	135	86	165	184	254	262	230
OPM OPM%	2.9	6.8	8.1	9.8	14.5	16.6	10.7	16.5	14.2	14.8	11.5	9.4
Other Income Other IncomeCr	7	14	12	16	13	13	15	-14	51	-56	23	21
Interest Expense Interest ExpenseCr	0	0	0	0	1	1	1	1	1	1	4	6
Depreciation DepreciationCr	17	16	15	15	19	20	17	16	15	40	29	17
PBT PBTCr	6	36	44	73	114	127	83	134	220	156	252	228
Tax TaxCr	1	15	18	18	42	34	21	35	58	41	65	59
PAT PATCr	5	20	26	54	72	93	62	99	162	116	188	170
Growth PAT Growth%	125.2	281.3	29.2	110.2	32.6	29.2	-34.0	61.2	62.7	-28.3	62.0	-7.5
NPM NPM%	0.9	3.7	4.5	7.5	8.7	11.5	7.7	9.9	12.5	6.7	8.2	7.0
EPS EPS₹	2.1	8.0	10.4	21.8	28.9	37.3	24.6	39.7	64.6	46.3	75.0	67.8

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Revenue RevenueCr	564	544	571	728	832	814	806	1,003	1,296	1,716	2,276	2,432
Growth Revenue Growth%	9.0	-3.5	5.0	27.6	14.2	-2.2	-1.0	24.5	29.2	32.5	32.6	31.1
Expenses ExpensesCr	547	507	525	657	711	678	719	838	1,111	1,462	2,014	2,202
Operating Profit Operating ProfitCr	16	37	46	71	121	135	86	165	184	254	262	230
OPM OPM%	2.9	6.8	8.1	9.8	14.5	16.6	10.7	16.5	14.2	14.8	11.5	9.4
Other Income Other IncomeCr	7	14	12	16	13	13	15	-14	51	-56	23	21
Interest Expense Interest ExpenseCr	0	0	0	0	1	1	1	1	1	1	4	6
Depreciation DepreciationCr	17	16	15	15	19	20	17	16	15	40	29	17
PBT PBTCr	6	36	44	73	114	127	83	134	220	156	252	228
Tax TaxCr	1	15	18	18	42	34	21	35	58	41	65	59
PAT PATCr	5	20	26	54	72	93	62	99	162	116	188	170
Growth PAT Growth%	125.2	281.3	29.2	110.2	32.6	29.2	-34.0	61.2	62.7	-28.3	62.0	-7.5
NPM NPM%	0.9	3.7	4.5	7.5	8.7	11.5	7.7	9.9	12.5	6.7	8.2	7.0
EPS EPS₹	2.1	8.0	10.4	21.8	28.9	37.3	24.6	39.7	64.6	46.3	75.0	67.8

Standalone

Numbers

Percentage

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	5	5	5	5	5	5	5	5	5	5	5
Reserves ReservesCr	151	218	242	296	359	451	506	584	707	765	868
Current Liabilities Current LiabilitiesCr	234	190	207	259	327	304	333	384	357	703	982
Non Current Liabilities Non Current LiabilitiesCr	13	2	7	2	15	15	13	12	9	45	135
Total Liabilities Total LiabilitiesCr	403	415	461	562	706	775	857	985	1,078	1,518	1,989
Current Assets Current AssetsCr	267	252	321	405	542	619	706	835	933	1,342	1,740
Non Current Assets Non Current AssetsCr	136	164	140	157	164	156	151	149	145	176	249
Total Assets Total AssetsCr	403	415	461	562	706	775	857	985	1,078	1,518	1,989

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital Equity CapitalCr	5	5	5	5	5	5	5	5	5	5	5
Reserves ReservesCr	151	218	242	296	359	451	506	584	707	765	868
Current Liabilities Current LiabilitiesCr	234	190	207	259	327	304	333	384	357	703	982
Non Current Liabilities Non Current LiabilitiesCr	13	2	7	2	15	15	13	12	9	45	135
Total Liabilities Total LiabilitiesCr	403	415	461	562	706	775	857	985	1,078	1,518	1,989
Current Assets Current AssetsCr	267	252	321	405	542	619	706	835	933	1,342	1,740
Non Current Assets Non Current AssetsCr	136	164	140	157	164	156	151	149	145	176	249
Total Assets Total AssetsCr	403	415	461	562	706	775	857	985	1,078	1,518	1,989

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	57	38	9	55	87	105	101	58	28	65	-15
Investing Cash Flow Investing Cash FlowCr	-4	0	-9	4	-171	173	5	18	22	31	19
Financing Cash Flow Financing Cash FlowCr	-1	0	0	0	-6	-9	-9	-24	-44	-66	-92
Net Cash Flow Net Cash FlowCr	53	38	-1	59	-90	269	96	52	5	31	-88
Free Cash Flow Free Cash FlowCr	48	33	3	37	74	99	94	53	18	64	-18
CFO To PAT CFO To PAT%	1,083.6	190.0	33.9	101.0	121.1	112.3	163.6	58.7	17.3	56.5	-8.1
CFO To EBITDA CFO To EBITDA%	347.1	103.1	19.0	77.1	72.4	77.3	117.0	35.3	15.1	25.7	-5.8

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating Cash Flow Operating Cash FlowCr	57	38	9	55	87	105	101	58	28	65	-15
Investing Cash Flow Investing Cash FlowCr	-4	0	-9	4	-171	173	5	18	22	31	19
Financing Cash Flow Financing Cash FlowCr	-1	0	0	0	-6	-9	-9	-24	-44	-66	-92
Net Cash Flow Net Cash FlowCr	53	38	-1	59	-90	269	96	52	5	31	-88
Free Cash Flow Free Cash FlowCr	48	33	3	37	74	99	94	53	18	64	-18
CFO To PAT CFO To PAT%	1,083.6	190.0	33.9	101.0	121.1	112.3	163.6	58.7	17.3	56.5	-8.1
CFO To EBITDA CFO To EBITDA%	347.1	103.1	19.0	77.1	72.4	77.3	117.0	35.3	15.1	25.7	-5.8

Standalone

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	2,892	2,352	2,316	4,996	5,979	7,526	6,389	8,118	13,301	21,516	19,399	15,185
Price To Earnings Price To Earnings	550.8	117.3	89.4	91.8	82.8	80.7	103.7	81.8	82.4	185.9	103.5	89.5
Price To Sales Price To Sales	5.1	4.3	4.1	6.9	7.2	9.3	7.9	8.1	10.3	12.5	8.5	6.2
Price To Book Price To Book	18.5	10.6	9.4	16.6	16.4	16.5	12.5	13.8	18.7	27.9	22.2	17.4
EV To EBITDA EV To EBITDA	171.4	60.5	47.3	67.6	47.5	53.0	69.0	46.2	69.4	82.8	72.7	63.5
Profitability Ratios Profitability Ratios
GPM GPM%	61.5	65.2	65.5	65.8	61.3	61.7	59.3	62.2	52.6	42.5	38.3	38.3
OPM OPM%	2.9	6.8	8.1	9.8	14.5	16.6	10.7	16.5	14.2	14.8	11.5	9.4
NPM NPM%	0.9	3.7	4.5	7.5	8.7	11.5	7.7	9.9	12.5	6.7	8.2	7.0
ROCE ROCE%	3.7	15.9	17.7	24.2	30.6	27.4	16.1	22.6	30.8	19.6	26.1	26.1
ROE ROE%	3.4	9.0	10.5	18.1	19.8	20.4	12.1	16.9	22.7	15.0	21.5	21.5
ROA ROA%	1.3	4.8	5.6	9.7	10.2	12.0	7.2	10.1	15.0	7.6	9.4	9.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

Financial Year	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Current
Valuation Ratios Valuation Ratios
Market Cap Market CapitalizationCr	2,892	2,352	2,316	4,996	5,979	7,526	6,389	8,118	13,301	21,516	19,399	15,185
Price To Earnings Price To Earnings	550.8	117.3	89.4	91.8	82.8	80.7	103.7	81.8	82.4	185.9	103.5	89.5
Price To Sales Price To Sales	5.1	4.3	4.1	6.9	7.2	9.3	7.9	8.1	10.3	12.5	8.5	6.2
Price To Book Price To Book	18.5	10.6	9.4	16.6	16.4	16.5	12.5	13.8	18.7	27.9	22.2	17.4
EV To EBITDA EV To EBITDA	171.4	60.5	47.3	67.6	47.5	53.0	69.0	46.2	69.4	82.8	72.7	63.5
Profitability Ratios Profitability Ratios
GPM GPM%	61.5	65.2	65.5	65.8	61.3	61.7	59.3	62.2	52.6	42.5	38.3	38.3
OPM OPM%	2.9	6.8	8.1	9.8	14.5	16.6	10.7	16.5	14.2	14.8	11.5	9.4
NPM NPM%	0.9	3.7	4.5	7.5	8.7	11.5	7.7	9.9	12.5	6.7	8.2	7.0
ROCE ROCE%	3.7	15.9	17.7	24.2	30.6	27.4	16.1	22.6	30.8	19.6	26.1	26.1
ROE ROE%	3.4	9.0	10.5	18.1	19.8	20.4	12.1	16.9	22.7	15.0	21.5	21.5
ROA ROA%	1.3	4.8	5.6	9.7	10.2	12.0	7.2	10.1	15.0	7.6	9.4	9.4
Operational Ratios Operational Ratios
Solvency Ratios Solvency Ratios
Liquidity Ratios Liquidity Ratios

	ABBOTINDIA	GLAXO	PFIZER	ASTRAZEN	PGHL	SANOFICONR	SANOFI
Market CapitalizationMkt CapCr	55,227	42,368	17,409	15,185	8,565	7,999	6,626
Close PriceClose₹	25,990.00	2,501.00	3,805.50	6,074.00	5,160.00	3,473.40	2,877.00
IndustryIndustry	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs
Price To EarningsPE	34.20	40.33	23.68	89.52	24.00	30.08	20.46
Price To SalesPS	7.88	10.71	6.77	6.24	5.98	8.42	3.67
RevenueRevenueCr	7,004	3,955	2,570	2,432	1,433	950	1,805
Revenue Growth TTMRev Gr TTM%	6.3%	5.8%	10.7%	31.1%	12.6%	31.2%	-8.9%
PAT Growth TTMPAT Gr TTM%	11.2%	12.4%	-9.1%	-7.5%	18.7%	33.0%	-10.7%

	ABBOTINDIA	GLAXO	PFIZER	ASTRAZEN	PGHL	SANOFICONR	SANOFI
Market CapitalizationMkt CapCr	55,227	42,368	17,409	15,185	8,565	7,999	6,626
Close PriceClose₹	25,990.00	2,501.00	3,805.50	6,074.00	5,160.00	3,473.40	2,877.00
IndustryIndustry	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs	Pharma MNC Bulk Drugs
Price To EarningsPE	34.20	40.33	23.68	89.52	24.00	30.08	20.46
Price To SalesPS	7.88	10.71	6.77	6.24	5.98	8.42	3.67
RevenueRevenueCr	7,004	3,955	2,570	2,432	1,433	950	1,805
Revenue Growth TTMRev Gr TTM%	6.3%	5.8%	10.7%	31.1%	12.6%	31.2%	-8.9%
PAT Growth TTMPAT Gr TTM%	11.2%	12.4%	-9.1%	-7.5%	18.7%	33.0%	-10.7%